====== Canadian Network for Advanced Interdisciplinary Methods ====== {{ ::canaim-logo.png?200|}} The **Canadian Network for Advanced Interdisciplinary Methods (CAN-AIM)** is a Canadian national research network based in [[canada:quebec:Montreal]], [[canada:Quebec]]. Its mandate is to enhance the validity and accuracy of research on drugs’ comparative effectiveness and safety. ===== Affiliations ===== The network is made up of 48 researchers from 12 universities and research centres from 6 Canadian provinces providing complementary clinical and methodological expertise, with representation from some institutions in the [[United States of America]].((//Who We Are.// CAN-AIM. Retrieved May 14, 2022, from https://canaim.ca/who-we-are/)) ==== Principal Investigators ==== ^ CAN-AIM Principal Investigators ^^^^ ^ Name ^ Specialty ^ Affiliation ^ Notes ^ | [[Sasha Bernatsky]] | [[Rheumatology]] | [[Research Institute of the McGill University Health Centre]] | - | | [[Louise Pilote]] | [[Internal medicine]] | [[McGill University]] | - | | [[Michal Abrahamowicz]] | [[Biostatistics]] | [[McGill University]], [[McGill University Health Centre]] | - | ==== Academia ==== Member universities in the CAN-AIM network include: * [[Dalhousie University]] * [[Laval University]] * [[McGill University]] * [[Memorial University of Newfoundland]] * [[Queen's University]] * [[Université de Sherbrooke]] * [[University of Alabama at Birmingham]] * [[University of Alberta]] * [[University of Calgary]] * [[University of British Columbia]] * [[University of Manitoba]] * [[University of Montreal]] * [[University of Ottawa]] * [[University of Toronto]] * [[University of Waterloo]] ==== Funding ==== CAN-AIM is funded by the [[Drug Safety and Effectiveness Network]] (DSEN) through a partnership between the [[Canadian Institutes of Health Research]] (CIHR) and [[Health Canada]].((//About CAN-AIM.// CAN-AIM. Retrieved May 14, 2022, from https://archive.ph/VFbba))